InMed Pharmaceuticals Subsidiary BayMedica LLC Sees Substantial Growth; Partnership For INM-755 Sought Jul 27, 2023
InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others… Jun 14, 2022
InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 9, 2022
